Understanding Myasthenia Gravis
Mechanisms of autoimmunity in myasthenia gravis
This work aims to better understand why the immune system attacks the body in Myasthenia Gravis, a condition causing muscle weakness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10904878 on NIH RePORTER |
What this research studies
Myasthenia Gravis causes severe muscle weakness because the body's immune system mistakenly creates antibodies that attack the connections between nerves and muscles. We know these antibodies interfere with muscle signals in a few ways, but the exact reasons for these attacks can differ between patients, especially depending on when their symptoms started. By looking closely at these differences, particularly in how the immune system behaves in the thymus gland, we hope to uncover the specific triggers and processes behind the disease. This deeper understanding is crucial for developing more effective and personalized treatments.
Who could benefit from this research
Good fit: This foundational research is relevant to all patients with Myasthenia Gravis, particularly those with different ages of onset.
Not a fit: Patients without Myasthenia Gravis would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to diagnose and treat Myasthenia Gravis by targeting the specific immune system problems in different patient groups.
How similar studies have performed: While the general mechanisms of Myasthenia Gravis are known, this work explores the specific, heterogeneous immunopathology, which is a less understood area.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: O'connor, Kevin C — Yale University
- Study coordinator: O'connor, Kevin C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.